Preterm infants T cell responses to

Journal of Infectious Diseases

Volumn 201, Issue 2, 2010, Pages 214-222

  Klein, Nicola P ^a,b   Gans, Hayley A ^b   Sung, Phillip ^b   Yasukawa, Linda L ^b   Johnson, Joanie ^a   Sarafanov, Andrey ^c   Chumakov, Konstantin ^c   Hansen, John ^a   Black, Steven ^d   Dekker, Cornelia L ^b  

^a KAISER PERMANENTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; POLIOMYELITIS VACCINE; VACCINE; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; IRRITABILITY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLIOMYELITIS; PREMATURITY; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; SWELLING; T LYMPHOCYTE ACTIVATION; TERM BIRTH; VACCINATION; BLOOD; CASE CONTROL STUDY; CELLULAR IMMUNITY; IMMUNOLOGY; MONOCYTE; NEWBORN; PROSPECTIVE STUDY; T LYMPHOCYTE;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MONOCYTES; POLIOVIRUS VACCINE, INACTIVATED; PROSPECTIVE STUDIES; T-LYMPHOCYTES; VACCINES, CONJUGATE;

EID: 75649133955     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/649590     Document Type: Article

References (46)

1. Saari TN. Immunization of preterm and low birth weight infants: American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 2003; 112:193-198.
2. D'Angio C, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenza, and polio immunizations. Pediatrics 1995;96:18-22.
3. D'Angio CT, Boohene PA, Mowrer A, et al. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. Pediatrics 2007;119:e574-e579.
4. 4. Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J 2002;21:182-186. (Pubitemid 34214132)
5. Esposito S, Pugni L, Bosis S, et al. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 2005;23:1703-1708.
6. 6. Slack MH, Cade S, Schapira D, et al. DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation. Arch Dis Child 2005;90:338-341. (Pubitemid 40488666)
7. Esposito S, Corbellini B, Bosis S, et al. Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine adminis- tered 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 2007;25:4889-4894.
8. Schloesser R, Fischer D, Otto W, Rettwitz-Volk W, Herden P, Zielen, S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999; 103:e60.
9. Slack M, Schapira D, Thwaites RJ, et al. Immune response of premature infants to meningococcal serogroup C and combined diptheria-tetanus toxoids-acellular pertussis-Haemopilus influenzae type b conjugate vaccine. J Infect Dis 2001; 184:1617-1620.
10. Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P, et al. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanusacellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116:1292-1298.
11. 11.BlondheimO,BaderD,AbendM,PeniakovM,ReichD.ImmunogenicityofhepatitisBvaccineinpreterminfants.ArchDisChildFetalNeonatalEd1998;79:F206-F208.(Pubitemid28500678)
12. Freitas da Motta M, Mussi-Pinhata MM, Jorge SM, Yoshida CFT, Sandoval de Souza CB. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine 2002;20:1557-1562.
13. Golebiowska M, Karda-Sobantka D, Chlebna-Sokol D, Sabanty W. Hepatitis B vaccination in preterm infants. Eur J Pediatr 1999; 158: 293-297.
14. 14. Linder N, Vishne TH, Levin E, et al. Hepatits B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination prototcols. Infection 2002;30:136-139. (Pubitemid 34606707)
15. 15.KimS,ChungEK,HodinkaRL,etal.ImmunogenicityofhepatitisBvaccineofpreterminfants.Pediatrics1997;99:534-536.(Pubitemid27176430)
16. 16. Belloni C, Chirico C, Pistorio A, Orsolini P, Tinelli C, Rondini G. Immonogenicity of hepatits B vaccine in term and preterm infants. Acta Paediatr 1998;87:336-338. (Pubitemid 28134276)
17. 17. Omenaca F, Garcia-Sicilia J, Boceta R, Sistiaga-Hernando A, GarciaCorbeira P. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely. Pediatr Infect Dis J 2007;26:824-829. (Pubitemid 47329855)
18. 18. Khalak R, Pichichero ME, D'Angio CT. Three-year follow-up of vaccine responses in extremely preterm infants. Pediatrics 1998; 101:597-603. (Pubitemid 28180140)
19. 19. Kirmani K, Lofthus G, Pichichero ME, Voloshen T, D'Angio C. Sevenyear follow-up of vaccine response in extremely premature infants. Pediatrics 2002; 109:498-504. (Pubitemid 34177515)
20. 20.AusielloC,UrbaniF,LaSalaA,LandeR,CassoneA.Vaccine-andantigen-dependenttype1andtype2cytokineinductionafterprimaryvaccinationofinfantswithwhole-celloracellularpertussisvaccines.InfectImmun1997;65:2168-2174.(Pubitemid27237293)
21. 21.ZeppF,KnufM,HabermehlP,etal.Pertussis-specificcell-mediatiedimmunityininfantsaftervaccinationwithatricomponentacellularpertussisvaccine.InfectImmun1996;64:4078-4084.(Pubitemid26318126)
22. Mascart F, Verscheure V, Malfroot A, et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol 2003;170:1504-1509.
23. 23. Rowe J, Macaubas C, Monger TM, et al. Antigen-specific responses to diptheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 2000; 68:3873-3877. (Pubitemid 30434535)
24. 24. Rowe J, Macaubas C, Monger T, et al. Heterogeneity in diptheriatetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic ThI function. J Infect Dis 2001; 184:80-88. (Pubitemid 32568504)
25. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Thltype immune response to Mycobacterium bcovis baccillus Calmette-Guerin vaccination. J Immunol 1999; 163:2249-2255.
26. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168: 919-925.
27. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Hepatitis B immu- nisation induces higher antibody and memory Th2 responses in newborns than in adults. Vaccine 2004;22:511-519.
28. Gans HA, Maldonado Y, Yasukawa LL, et al. IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J Immunol 1999; 162:5569-5575.
29. 9. Groothuis JR, Levin MJ, Lehr MV, Weston JA, Hayward AR. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine 1992; 10:221-225.
30. Juhela S, Hyoty H, Lonnrot M, Roivainen M, Simell O, Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998; 54:226-232.
31. Vekemans J, Ota MOC, Wang ECY, et al. T cell responses to vaccines in infants: defective IFNg production after oral polio vaccination. Clin Exp Immunol 2002; 127:495-498.
32. Pfister RE, Aeschbach V, Niksic-Stuber V, Martin BC, Siegrist CA. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr 2004; 145:58-66.
33. Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008; 121:463-469.
34. Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. Immune responses to mumps vaccine in adults who were vaccinated in childhood. J Infect Dis 2008; 197:1669-1675.
35. Gans HA, Yasukawa LL, Zhang CZ, et al. Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. Viral Immunol 2008;21:163-172.
36. Gans HA, Yasukawa LL, Alderson A, et al. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis 2004; 190:83-90.
37. World Health Organization (WHO). Manual for the virological investigation of polio (WHO/EPI/GEN/97.01). Geneva, Switzerland: WHO, 1997.
38. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345:567-569.
39. 39.ChabraS,CottrillC,RayensMK,CrossR,LipkeD,BruceM.Lymphocytesubsetsincordbloodofpreterminfants:effectofantenatalsteroids.BiolNeonate1998;74:200-207.(Pubitemid28391292)
40. 40.JureticE,UzarevicB,PetroveckiM,JureticA.Two-colorflowcytometricanalysisofpretermandtermnewbornlymphocytes.Immunobiology2000;202:421-428.(Pubitemid32058661)
41. 41. Perez A, Gurbindo MD, Resino S, Aguaron A, Munoz-Fernandez MA. NK cell increase in neonates from the preterm to the full-term period of gestation. Neonatology 2007;92:158-163. (Pubitemid 47442992)
42. 42. Berrington JE, Barge D, Fenton AC, Cant AJ, Spickett GP. Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry. Clin Exp Immunol 2005; 140:289-292. (Pubitemid 40559155)
43. Fleischer B. Superantigens. Behring Inst Mitt 1994:104-112.
44. 44. Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper l cells. Eur J Immunol 1996; 26:659-668. (Pubitemid 26091397)
45. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
46. 46. Fuleihan R, Ahem D, Geha RS. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol 1994;24:1925-1928. (Pubitemid 24237569)